Experiences with the Homozygous Cases of Familial Hypercholesterolemia
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lebanese are at particular high risk for familial hypercholesterolemia, a combined result of founder mutations and high incidence of consanguinity [23,24].”
From Dementia prevalence, care arrangement and access to care in Lebanon: a pilot study (2017) · cites this paper as [24]
In the citing paper
“In line with this, loss-of-function LDLR mutations are associated with elevated plasma LDL levels and cardiovascular risk.11–13”
From (Pro)renin Receptor Inhibition Reprograms Hepatic Lipid Metabolism and Protects Mice From Diet-Induced Obesity and Hepatosteatosis (2018) · cites this paper as [12]
Citations
Cites
The inheritance of essential familial hypercholesterolemia
Khachadurian, A. K. (1964) · The American Journal of Medicine · doi:10.1016/0002-9343(64)90196-2 · Cited by 280
Self-citationThe inheritance of familial hypercholesterolemia
Jensen, J., & Blankenhorn, D. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90041-1 · Cited by 95
Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia)
Khachadurian, A. K. (1968) · Arthritis & Rheumatism · doi:10.1002/art.1780110303 · Cited by 78
Self-citationKhachadurian, A. K., & Demirjian, Z. N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80091-2 · Cited by 51
Self-citation
Cited by
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin, M. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh236 · Cited by 657
Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., et al. (2001) · Science · doi:10.1126/science.1060458 · Cited by 624
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18925 · Cited by 560
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
Rader, D. J., Cohen, J., & Hobbs, H. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318925 · Cited by 450
Hopkins, P. N., Toth, P. P., Ballantyne, C. M., & Rader, D. J. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.03.452 · Cited by 351
Regulation of glucose and lipid metabolism in health and disease
Chen, L., Chen, X.-W., Huang, X., Song, B.-L., Wang, Y., & Wang, Y. (2019) · Science China Life Sciences · doi:10.1007/s11427-019-1563-3 · Cited by 306
“and Uthman first described what is now called “autosomal recessive hypercholesterolemia” (Khachadurian and Uthman, 1973; Zuliani et al., 1999).”
BackgroundHobbs, H. H., Brown, M. S., Russell, D. W., Davignon, J., & Goldstein, J. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171204 · Cited by 301
Common low-density lipoprotein receptor mutations in the French Canadian population.
Leitersdorf, E., Tobin, E. J., Davignon, J., & Hobbs, H. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114531 · Cited by 302
Lehrman, M. A., Schneider, W. J., Brown, M. S., Davis, C. G., Elhammer, A., Russell, D. W., & Goldstein, J. L. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75941-9 · Cited by 282
Vallejo-Vaz, A. J., De Marco, M., Stevens, C. A. T., Akram, A., Freiberger, T., Hovingh, G. K., Kastelein, J. J. P., Mata, P., Raal, F. J., Santos, R. D., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.08.051 · Cited by 231
“HoFH is 10-fold higher than in other populations), attributable to founder effects and high consanguinity rates [26,27].”
BackgroundCardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients
Sprecher, D. L., Schaefer, E. J., Kent, K. M., Gregg, R. E., Zech, L. A., Hoeg, J. M., McManus, B., Roberts, W. C., & Brewer, H. B. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90298-4 · Cited by 230
SCHAEFER, E. J., ZECH, L. A., SCHWARTZ, D. E., & BREWER, H. B. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-2-261 · Cited by 220
Schaefer, E. J., Levy, R. I., Ernst, N. D., Van Sant, F. D., & Brewer, H. B. (1981) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/34.9.1758 · Cited by 211
Arnett, D. K., Baird, A. E., Barkley, R. A., Basson, C. T., Boerwinkle, E., Ganesh, S. K., Herrington, D. M., Hong, Y., Jaquish, C., McDermott, D. A., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.183679 · Cited by 200
Familial Hypercholesterolemia—Epidemiology, Diagnosis, and Screening
Singh, S., & Bittner, V. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0482-5 · Cited by 195
(1976) · Current Topics in Cellular Regulation · doi:10.1016/b978-0-12-152811-9.50011-0 · Cited by 137
Homozygous familial hypercholesterolemia among French Canadians in Québec Province.
Moorjani, S., Roy, M., Gagné, C., Davignon, J., Brun, D., Toussaint, M., Lambert, M., Campeau, L., Blaichman, S., & Lupien, P. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.2.211 · Cited by 179
Mishra, S. K., Watkins, S. C., & Traub, L. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252630799 · Cited by 155
Arca, M., Zuliani, G., Wilund, K., Campagna, F., Fellin, R., Bertolini, S., Calandra, S., Ricci, G., Glorioso, N., Maioli, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07955-2 · Cited by 136
A host of hypercholesterolaemic homozygotes in South Africa.
Seftel, H. C., Baker, S. G., Sandler, M. P., Forman, M. B., Joffe, B. I., Mendelsohn, D., Jenkins, T., & Mieny, C. J. (1980) · BMJ · doi:10.1136/bmj.281.6241.633 · Cited by 152
TYBJARGHANSEN, A., & Humphries, S. E. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90056-m · Cited by 146
Genetic and molecular architecture of familial hypercholesterolemia
Abifadel, M., & Boileau, C. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13577 · Cited by 176
Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors
Remaley, A. T., Rifai, N., & Warnick, G. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00027-5 · Cited by 144
Ganesh, S. K., Arnett, D. K., Assimes, T. L., Basson, C. T., Chakravarti, A., Ellinor, P. T., Engler, M. B., Goldmuntz, E., Herrington, D. M., Hershberger, R. E., et al. (2013) · Circulation · doi:10.1161/01.cir.0000437913.98912.1d · Cited by 127
Heterozygous familial hypercholesterolemia
Gagné, C., Moorjani, S., Brun, D., Toussaint, M., & Lupien, P. J. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90101-1 · Cited by 134
Molecular mechanisms of autosomal recessive hypercholesterolemia
Wilund, K. R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.24.3019 · Cited by 113
Common and Rare ABCA1 Variants Affecting Plasma HDL Cholesterol
Wang, J., Burnett, J. R., Near, S., Young, K., Zinman, B., Hanley, A. J. G., Connelly, P. W., Harris, S. B., & Hegele, R. A. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1983 · Cited by 121
Genetics, Clinical Phenotype, and Molecular Cell Biology of Autosomal Recessive Hypercholesterolemia
Soutar, A. K., Naoumova, R. P., & Traub, L. M. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000094410.66558.9a · Cited by 99
A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.
Meiner, V., Landsberger, D., Berkman, N., Reshef, A., Segal, P., Seftel, H. C., van der Westhuyzen, D. R., Jeenah, M. S., Coetzee, G. A., & Leitersdorf, E. (1991) · Europe PMC (PubMed Central) · Cited by 105
Aging and atherosclerosis in the rabbit
Spagnoli, L. G., Orlandi, A., Mauriello, A., Santeusanio, G., de Angelis, C., Lucreziotti, R., & Ramacci, M. T. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90003-l · Cited by 110
INCREASED BLOOD VISCOSITY AND FIBRINOLYTIC INHIBITOR IN TYPE II HYPERLIPOPROTEINAEMIA
Lowe, G. D. O. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91450-7 · Cited by 101
Pisciotta, L., Oliva, C. P., Pes, G. M., Di Scala, L., Bellocchio, A., Fresa, R., Cantafora, A., Arca, M., Calandra, S., & Bertolini, S. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.016 · Cited by 98
Abifadel, M., Rabès, J.-P., Jambart, S., Halaby, G., Gannagé-Yared, M.-H., Sarkis, A., Beaino, G., Varret, M., Salem, N., Corbani, S., et al. (2009) · Human Mutation · doi:10.1002/humu.21002 · Cited by 99
Current management of severe homozygous hypercholesterolaemias
Naoumova, R. P., Thompson, G. R., & Soutar, A. K. (2004) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000137222.23784.2a · Cited by 96
Streja, D. A., Steiner, G. A., & Kwiterovich, P. O. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-871 · Cited by 94
Fellin, R., Arca, M., Zuliani, G., Calandra, S., & Bertolini, S. (2014) · Gene · doi:10.1016/j.gene.2014.09.020 · Cited by 99
“They investigated four families: two from Sardinia and two from Lebanon, including the original family with this disorder reported by Khachadurian and Uthman (1973).”
BackgroundFamilial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution
Liyanage, K. E., Burnett, J. R., Hooper, A. J., & BOCKXMEER, F. M. V. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.565585 · Cited by 88
“(1) Bakola Pygmies, (2) Baka Pygmies, (3) Ateke Bantus, (4) Somali, (5) Moroccans, (6) Ashkenazi Jews, (7) Sardinians, (8) Swedes, (9) Saami, (10) Turkomen, (11) Gujarati, (12) Thai, (13) Chinese, (14) Yorubas, (15) Zimbabweans, (16) South Africans, (17) Libyans, (18) Saudi Arabians, (19) Emiratis, (20) Iranians, (21)…”
Abnormalities of blood rheology in familial hypercholesterolaemia: effects of treatment
Jay, R. H., RAMPLING, M. W., & Betteridge, D. J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90117-2 · Cited by 74
Plasma-Exchange Therapy of Homozygous Familial Hypercholesterolemia
King, M. E., Breslow, J. L., & Lees, R. S. (1980) · New England Journal of Medicine · doi:10.1056/nejm198006263022607 · Cited by 74
Li, J., Fang, B., Eisensmith, R. C., Li, X., Nasonkin, I. O., Lin-Lee, Y.-C., Mims, M. P., Hughes, A., Montgomery, C., & Roberts, J. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117725 · Cited by 72
Sprecher, D. L., Hoeg, J. M., Schaefer, E. J., Zech, L. A., Gregg, R. E., Lakatos, E., & Brewer, H. B. (1985) · Metabolism · doi:10.1016/0026-0495(85)90015-0 · Cited by 76
Coronary artery disease in heterozygous familial hypercholesterolemia
Hirobe, K., Matsuzawa, Y., ISHIKAWA, K., Tarui, S., Yamamoto, A., NAMBU, S., & Fujimoto, K. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90114-9 · Cited by 73
Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia
Burnett, J., Bell, Hooper, & Watts (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s28581 · Cited by 64
Genetic Mutations Affecting Human Lipoprotein Metabolism
Zannis, V. I., & Breslow, J. L. (1985) · Advances in Human Genetics 14 · doi:10.1007/978-1-4615-9400-0_3 · Cited by 65
Familial hypercholesterolemia—Improving treatment and meeting guidelines
Hopkins, P. N. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00420-5 · Cited by 71
Bétard, C., Kessling, A. M., Roy, M., Chamberland, A., Lussier‐Cacan, S., & Davignon, J. (1992) · Human Genetics · doi:10.1007/bf00219339 · Cited by 63
“1987), Lebanon (Khachadurian and Uthman 1973; Lehrman et al. 1987), and Finland (Aalto-Settil~i et al.”
BackgroundHomozygous familial hypercholesterolemia in Japan
Mabuchi, H., Tatami, R., Haba, T., Ueda, K., Ueda, R., KAMETANI, T., Itoh, S., Koizumi, J., Oota, M., Miyamoto, S., et al. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90822-7 · Cited by 67
Molecular mechanisms of autosomal recessive hypercholesterolemia
Cohen, J. C., Kimmel, M., Polanski, A., & Hobbs, H. H. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00002 · Cited by 52
Homozygous familial hypercholesterolemia in Lebanon: A genotype/phenotype correlation
Fahed, A. C., Safa, R., Haddad, F. F., Bitar, F. F., Andary, R. R., Arabi, M. T., Azar, S. T., & Nemer, G. M. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.11.006 · Cited by 66
Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia
Jones, C., Garuti, R., Michaely, P., Li, W.-P., Maeda, N., Cohen, J. C., Herz, J., & Hobbs, H. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29415 · Cited by 52
“In 1973, Khachadurian and Uthman described a Lebanese family with an autosomal recessive form of severe hypercholesterolemia that was clinically indistinguishable from FH (2).”
BackgroundRen, L., Sun, Y., Lu, H., Ye, D., Han, L., Wang, N., Daugherty, A., Li, F., Wang, M., Su, F., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.312422 · Cited by 59
Schneider, S. H., Kim, H. C., Khachadurian, A. K., & Ruderman, N. B. (1988) · Metabolism · doi:10.1016/0026-0495(88)90148-5 · Cited by 58
Self-citationLind, S., Olsson, A. G., Eriksson, M., Rudling, M., Eggertsen, G., & Angelin, B. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01401.x · Cited by 58
Clinical Features and Genetic Analysis of Autosomal Recessive Hypercholesterolemia
Harada-Shiba, M., Takagi, A., Miyamoto, Y., Tsushima, M., Ikeda, Y., Yokoyama, S., & Yamamoto, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021487 · Cited by 57
Dementia prevalence, care arrangement and access to care in Lebanon: a pilot study
Phung, K. T. T., Chaaya, M., Prince, M., Atweh, S., El Asmar, K., Karam, G., Khoury, R. M., Ghandour, L., Ghusn, H., Nielsen, T. R., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.04.007 · Cited by 56
“Lebanese are at particular high risk for familial hypercholesterolemia, a combined result of founder mutations and high incidence of consanguinity [23,24].”
BackgroundAhmad, Z., Adams-Huet, B., Chen, C., & Garg, A. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.112.963587 · Cited by 55
Dyslipidaemia in the Middle East: Current status and a call for action
Al‐Rasadi, K., Almahmeed, W. A., AlHabib, K. F., Abifadel, M., Farhan, H. A., Alsifri, S. N., Jambart, S., Zubaid, M., Awan, Z. A., Al-Waili, K., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.925 · Cited by 58
Gudnason, V. G., King‐Underwood, L., Seed, M., Sun, X. M., Soutar, A. K., & Humphries, S. E. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.1.56 · Cited by 52
Lupien, P.-J., Moorjani, S., Lou, M., Brun, D., & Gagné, C. (1980) · Pediatric Research · doi:10.1203/00006450-198002000-00009 · Cited by 51
Farah, J. R., Kwiterovich, P., & Neill, C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91078-9 · Cited by 54
Hyperlipidaemia due to isotretinoin and etretinate: possible mechanisms and consequences
Marsden, J. R. (1986) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1986.tb02842.x · Cited by 50
“Conversely, although catabolism of LDL is grossly impaired in familial hypercholesterolaemia, levels of triglyceride and VLDL cholesterol are usually not increased (Khachadurian & Uthman, 1973).”
BackgroundPhenotypic expression of familial hypercholesterolaemia in Central and Southern Tunisia
Slimane, M. N., Pousse, H., Maatoug, F., Hammami, M., & Ben-Farhat, M. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90186-x · Cited by 49
Is there a genetic basis for resistance to atherosclerosis?
Stein, O., Thiery, J., & Stein, Y. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00664-5 · Cited by 57
Familial hypercholesterolemia and triglyceride metabolism
Kolovou, G. D., Kostakou, P. M., & Anagnostopoulou, K. K. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.009 · Cited by 48
Autosomal recessive hypercholesterolaemia: long-term follow up and response to treatment
Naoumova, R. P., Neuwirth, C. K. Y., Lee, P., Miller, J. P., Taylor, K. G., & Soutar, A. K. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.020 · Cited by 42
Kaloustian, V. M. D., Naffah, J., Loiselet, J., & Optiz, J. M. (1980) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320070212 · Cited by 41
Goldstein, J. L., Harrod, M. J. E., & Brown, M. S. (1974) · Europe PMC (PubMed Central) · Cited by 41
Stehbens, W. E., & Wierzbicki, E. (1988) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(88)90020-5 · Cited by 41
Coronary Heart Disease, Hypercholesterolemia, and Atherosclerosis I. False Premises
Stehbens, W. E. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2000.2340 · Cited by 42
Sitosterol in juvenile type II hyperlipoproteinemia
Schlierf, G., Oster, P., Heuck, C. C., Raetzer, H., & Schellenberg, B. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90116-8 · Cited by 39
Gudnason, V. G., Sigurðsson, G., Nissen, H., & Humphries, S. E. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:1<84::aid-humu14>3.0.co;2-w · Cited by 37
Molecular genetics of familial hypercholesterolemia in Israel
Reshef, A., Nissen, H., Triger, L., Hensen, T. S., Eliav, O., Schurr, D., Safadi, R., Gare, M., & Leitersdorf, E. (1996) · Human Genetics · doi:10.1007/s004390050263 · Cited by 37
“Previous studies revealed that in several relatively isolated populations there is an increased frequency of FH ( Khachadurian and Uthman 1973; Moorjani et al. 1989; Seftel et al. 1980).”
ResultLipid metabolism and retinoid therapy
Marsden, J. R. (1989) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(89)90074-0 · Cited by 37
Screening for familial hypercholesterolaemia
Bender, R., Bell, D. A., Hooper, A. J., Edwards, G., BOCKXMEER, F. M. V., Watts, G. F., & Burnett, J. R. (2012) · Pathology · doi:10.1097/pat.0b013e32834efa07 · Cited by 39
“Without treatment, FH homozygotes do not usually survive beyond age 30 years.(20)”
BackgroundDietary Recommendations for Familial Hypercholesterolaemia: an Evidence-Free Zone
Diamond, D. M., Alabdulgader, A., de Lorgeril, M., Harcombe, Z., Kendrick, M. E., Malhotra, A., O’Neill, B. J., Ravnskov, U., Sultan, S., & Volek, J. S. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111412 · Cited by 38
Page, M. M., Bell, D. A., Hooper, A. J., Watts, G. F., & Burnett, J. R. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.10.004 · Cited by 39
Carter, G. A., CONNOR, W. E., Bhattacharyya, A. K., & Lin, D. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40652-2 · Cited by 34
Dvir, H., Shah, M., Girardi, E., Guo, L., Farquhar, M. G., & Zajonc, D. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114128109 · Cited by 30
“The first significant clue came a decade later from studies of patients with autosomal recessive hypercholesterolemia (ARH), who were described as clinically similar to FH patients but carried no LDLR mutations (8).”
BackgroundIdentification of a VLDL‐induced, FDNPVY‐independent internalization mechanism for the LDLR
Michaely, P., Zhao, Z., Li, W., Garuti, R., Huang, L. J.-S., Hobbs, H. H., & Cohen, J. C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601769 · Cited by 31
“Interestingly, ARH deficiency in humans is characterized by the formation of large xanthomas, which are cholesterol ester-rich deposits formed by macrophages (Khachadurian and Uthman, 1973; Harada-Shiba et al, 2003).”
BackgroundLow-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia
Vella, A. V., Pineda, A. A., & O’Brien, T. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.10.1039 · Cited by 31
Millar, J. S., & Lagor, W. R. (2009) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s6033 · Cited by 40
Maartmann‐Moe, K., & Berg‐Johnsen, P. (1981) · Clinical Genetics · doi:10.1111/j.1399-0004.1981.tb01814.x · Cited by 29
Leitersdorf, E. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1130-0_17 · Cited by 26
Ahmad, Z., Li, X., Wosik, J., Mani, P., Petr, J., McLeod, G., Murad, S., Song, L., ADAMS-HUET, B. A., & Garg, A. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.09.003 · Cited by 26
Defesche, J. C., van Diermen, D. E., Lansberg, P. J., Lamping, R. J., Reymer, P. W. A., Hayden, M. R., & Kastelein, J. J. P. (1993) · Human Genetics · doi:10.1007/bf00420940 · Cited by 25
“However, in some populations, such as the French-Canadians, Christian Lebanese, and South African Afrikaners, the incidence o f heterozygous FH is much higher, with a f requency of up to 1 in 50 persons in certain areas (Khachadurian and Uthman 1973; Seftel et al. 1980; Hobbs et al. 1987; Steyn et al. 1989).”
BackgroundMcNamara, D. J., AHRENS, E. H., Kolb, R., Brown, C. D., Parker, T. S., Davidson, N. O., Samuel, P., & McVie, R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.2.564 · Cited by 27
Tada, H., Kawashiri, M., Nohara, A., Inazu, A., Kobayashi, J., Mabuchi, H., & Yamagishi, M. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.27227 · Cited by 26
Harada-Shiba, M., Takagi, A., Marutsuka, K., Moriguchi, S., Yagyu, H., Ishibashi, S., Asada, Y., & Yokoyama, S. (2004) · Circulation Research · doi:10.1161/01.res.0000146946.78540.46 · Cited by 21
Martínez‐Hervás, S., & Ascaso, J. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65340-0 · Cited by 32
Familial homozygous hypercholesterolemia: Clinical and cardiovascular features in 18 patients
Brook, G. J., Keidar, S., Boulos, M., Grenadier, E., Wiener, A., Shehada, N., Markiewicz, W., Benderli, A., & Aviram, M. (1989) · Clinical Cardiology · doi:10.1002/clc.4960120608 · Cited by 23
Molecular genetics of familial hypercholesterolemia in Israel–revisited
Durst, R. Y., Ibe, U. K., Shpitzen, S., Schurr, D., Eliav, O., Futema, M., Whittall, R., Szalat, A., Meiner, V., Knobler, H., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.12.021 · Cited by 23
“Previous studies revealed that in several relatively isolated populations, there is an increased frequency of FH (7-9).”
BackgroundHomozygous familial hypercholesterolemia: Summarized case reports
Widhalm, K., Benke, I. M., Fritz, M., Geiger, H., Helk, O., Fritsch, M., Hoermann, G., & Kostner, G. M. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.01.002 · Cited by 23
Pregnancy, parturition, and lactation in familial homozygous hypercholesterolemia
Tsang, R. C., Glueck, C. J., McLain, C. R., Russell, P. T., Joyce, T. H., Bove, K., Mellies, M. J., & Steiner, P. M. (1978) · Metabolism · doi:10.1016/0026-0495(78)90217-2 · Cited by 22
Ten LDL Receptor Mutants Explain One Third of Familial Hypercholesterolemia in a German Sample
Schuster, H., Keller, C., Wolfram, G., & Zöllner, N. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2176 · Cited by 22
Oppenheim, A., Friedlander, Y., Dann, E. J., Berkman, N., Schwarte, S., & Leitersdorf, E. (1991) · Human Genetics · doi:10.1007/bf00204933 · Cited by 22
“However, in several population groups the disease is much more common (Khachadurian and Uthman 1973; Seftel et al. 1980; Moorjani et al. 1989).”
Fung, C. H., Khachadurian, A. K., Ching-Hua, W., & Durr, I. F. (1977) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(77)90215-6 · Cited by 22
Self-citationAutosomal recessive hypercholesterolemia in Spain
Sánchez-Hernández, R. M., Prieto‐Matos, P., Civeira, F., Lafuente, E. E., Vargas, M. F., Real, J. T., Goñi, F., Fuentes, F. J., Pocoví, M., Boronat, M., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.006 · Cited by 24
Abnormalities of high density lipoproteins in homozygous familial hypercholesterolemia.
Goldberg, R. B., Fless, G. M., Baker, S. G., Joffe, B. I., Getz, G. S., Scanu, A. M., & Seftel, H. C. (1984) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.4.5.472 · Cited by 21
Sequence Diversity in Genes of Lipid Metabolism
Garcia, C. K., MUES, G. I., Liao, Y., Hyatt, T., Patil, N., Cohen, J. C., & Hobbs, H. H. (2001) · Genome Research · doi:10.1101/gr.172301 · Cited by 24
“Twelve of these samples were from probands with presumed autosomal recessive hypercholesterolemia, who had marked elevations in plasma cholesterol, tendon xanthomas, and normolipidemic parents (Khachadurian and Uthman 1973; Sirtori et al. 1991; Zuliani et al. 1995).”
Background
Metadata
- Authors
- Khachadurian, A. K., & Uthman, S. M.
- Affiliations
- Northwestern University (US)
- Corresponding author
- Khachadurian, A.K.
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 1973
- Volume
- 15
- Issue
- 1-2
- Pages
- 132-140
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W2025664844
- Cited by
- 185
- References
- 4
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 8
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Annals of Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- familial hypercholesterolemia, homozygous familial hypercholesterolemia, hypercholesterolemia, lipid metabolism disorders
- MeSH terms
- Adolescent, Adult, Blood Protein Disorders, Child, Child, Preschool, Cholesterol, Cholestyramine Resin, Female, Homozygote, Humans, Hypercholesterolemia, Lipids, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Male, Nicotinic Acids, Xanthomatosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.